Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on OGXI
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
OncoGenex Pharmaceuticals, Inc. (NQ:OGXI)
Delayed:
9.52
-0.51 (5.08%)
Trade Now!
Previous Close
$10.03
52 Week High
$14.99
Open
$10.00
52 Week Low
$9.16
Day High
$10.00
P/E
N/A
Day Low
$9.43
EPS
$-1.42
Volume
5,000
Friends, Peers and Foes
(?)
:
TEVA
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 18, 2013 04:20 PM
Form 8-K ONCOGENEX PHARMACEUTICAL For: Jun 18
Jun 10, 2013 11:09 AM
Form SC 13G/A ONCOGENEX PHARMACEUTICAL Filed by: FMR LLC
May 29, 2013 04:55 PM
Form 8-K ONCOGENEX PHARMACEUTICAL For: May 24
May 28, 2013 12:35 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: Smith David V
May 28, 2013 12:33 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: PARKER H STEWART
May 28, 2013 12:32 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: MATTINGLY MARTIN A
May 28, 2013 12:31 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: GOLDSTEIN JACK
May 28, 2013 12:25 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: Clendeninn Neil James
May 28, 2013 06:30 AM
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
May 23, 2013 06:30 AM
OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
View All Articles
Mar 7, 2013 04:09 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Reports Q4 Loss of $0.28
Nov 8, 2012 04:55 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c
Mar 8, 2012 05:20 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Posts Q4 Loss of 98c/Share
Nov 3, 2011 05:17 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Reports Q3 Earnings of $0.45
May 1, 2013 06:42 AM
OncoGenex (OGXI) to Initiate OGX-427 Phase 2 in Combo with ABRAXANE
Mar 7, 2013 04:09 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Reports Q4 Loss of $0.28
Feb 4, 2013 05:44 PM
OncoGenex (OGXI) CFO Burns Resigns; Has 'Developing Relationship' with CEO Cormack
Dec 19, 2012 09:33 AM
OncoGenex (OGXI) Commences OGX-427 Phase 2 in CRPC
Nov 8, 2012 04:55 PM
OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c
Nov 8, 2012 04:42 PM
OncoGenex Pharma (OGXI) Files $100M Mixed Shelf
Nov 7, 2012 03:38 PM
Trading Radar for 11/08: Disney (DIS), Lannett (LCI), Allscripts (MDRX), Wendy's (WEN) Report
Sep 27, 2012 04:33 PM
OncoGenex (OGXI) Initiates Custirsen Phase 3 for NSCLC
Aug 3, 2012 09:43 AM
Needham & Company Maintains a 'Buy' on OncoGenex Pharmaceuticals (OGXI); Custersin and OGX-427 Development Remain on Track
View All Reports
May 28, 2013 06:30 AM
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
May 23, 2013 06:30 AM
OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
May 22, 2013 06:30 AM
OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting
May 2, 2013 04:00 PM
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
May 1, 2013 06:30 AM
OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
Apr 30, 2013 08:00 AM
OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment
Apr 25, 2013 04:01 PM
OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013
Apr 23, 2013 04:01 PM
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
View All Press Releases
Jun 18, 2013 04:20 PM
Form 8-K ONCOGENEX PHARMACEUTICAL For: Jun 18
Jun 10, 2013 11:09 AM
Form SC 13G/A ONCOGENEX PHARMACEUTICAL Filed by: FMR LLC
May 29, 2013 04:55 PM
Form 8-K ONCOGENEX PHARMACEUTICAL For: May 24
May 28, 2013 12:35 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: Smith David V
May 28, 2013 12:33 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: PARKER H STEWART
May 28, 2013 12:32 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: MATTINGLY MARTIN A
May 28, 2013 12:31 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: GOLDSTEIN JACK
May 28, 2013 12:25 PM
Form 4 ONCOGENEX PHARMACEUTICAL For: May 23 Filed by: Clendeninn Neil James
May 2, 2013 04:17 PM
Form 10-Q ONCOGENEX PHARMACEUTICAL For: Mar 31
May 2, 2013 04:10 PM
Form 8-K ONCOGENEX PHARMACEUTICAL For: May 02
View All Filings
Entities mentioned with
OGXI
Earnings
|
View Related Stories »
Needham & Company
|
View Related Stories »
Morning Movers
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Cerberus Capital
|
View Related Stories »
Dividend
|
View Related Stories »
Trading Radar
|
View Related Stories »
Bankruptcy
|
View Related Stories »
Citi
|
View Related Stories »
Bank of America
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Fidelity Investments
|
View Related Stories »
Goldman Sachs
|
View Related Stories »
13G
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
Soleil Securities
|
View Related Stories »
William Blair
|
View Related Stories »
Duke Energy/Progress Energy, Inc.
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Wells Fargo
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
FDIC
|
View Related Stories »
Show More...
View All Entities